Suzuki Motor (7269.T) traded up 0.8 % during a 24 hours period ending at 10:33 PM Central Europe on Tuesday 27th. One Suzuki Motor stock can currently be bought for about JPY 2,074 on popular exchanges. Current supply of Suzuki Motor stocks is 1.9 bn. Suzuki Motor has a current market capitalization of JPY 4 trillions and approximately JPY 13.6 bn worth of Suzuki Motor was traded on exchanges in the last 24 hours. Since last month end, Suzuki Motor has traded 5.27 % up. Simple moving average of last 200 days is at JPY 2,031.04. The highest price of past 52 weeks was recorded at JPY 2,473 on 11/27/2025. 52 weeks low was at JPY 1,670 on 04/07/2026.

Summary of the latest news for Suzuki Motor

Suzuki Motor Corp. is expected to release its latest quarterly financial results on November 10, 2026, covering the period ended September 30. Analysts project a modest earnings‑per‑share figure for the quarter, slightly lower than the same period a year earlier, and anticipate revenue to rise in comparison to the preceding year’s quarter. For the full fiscal year, consensus estimates suggest a small increase in earnings per share relative to the previous year, while revenue is forecast to grow modestly. The company’s forthcoming disclosure will provide the market with a clearer view of its performance trajectory amid ongoing industry dynamics.

Here is how related stocks have performed in the past 24 hours:

  • Astellas Pharma (4503.T) traded up 1.85 % and now trades at JPY 2,518. Current market capitalisation for Astellas Pharma is JPY 4.6 trillions. Astellas Pharma has a current price to earnings ratio of 12.63. Astellas Pharma Inc. has announced a significant development in its oncology pipeline following the FDA’s approval of a new treatment combination for metastatic prostate cancer. The company’s therapy, combining a poly‑ADP ribose polymerase inhibitor with an androgen receptor pathway inhibitor, has now been authorized for use in men with hormone‑sensitive disease carrying homologous recombination repair mutations. The approval extends the indication from previously treated resistant disease to an earlier treatment setting, potentially offering patients an option that could delay disease progression. The decision was supported by phase‑III data demonstrating a notable reduction in radiographic progression risk and a durable progression‑free benefit across both BRCA and non‑BRCA mutation subgroups. Safety findings remain consistent with the known profiles of each component, and the combination is expected to broaden treatment options for patients with genetic biomarkers that predict response.

  • Nomura (8604.T) traded down -0.39 % and now trades at JPY 1,439. Nomura has a market capitalisation of JPY 4.2 trillions. Current price/earnings ratio for Nomura is 10.66. Nomura Holdings Inc. filed a Form 6‑K with the U.S. Securities and Exchange Commission on October 27, 2026, reporting its consolidated capital adequacy, leverage, and external TLAC ratios for the period ended June 30, 2026. The filing cited the company’s regulatory capital status, noting that capital ratios remained well above regulatory thresholds and that leverage and TLAC coverage were within acceptable ranges. The report also referenced the company’s most recent annual filing and provided a link to the investor information on its website. No commentary on market performance or earnings was included in the filing. No other material corporate events were disclosed in the filing for that date.

  • Denso (6902.T) traded up 0.3 % and now trades at JPY 1,832. Current market capitalisation for Denso is JPY 4.6 trillions. Current price/earnings ratio for Denso is 11.61.

  • Sumitomo Mitsui (8309.T) traded up 0.41 % and now trades at JPY 1,643.5. Sumitomo Mitsui has a market capitalisation of JPY 4.4 trillions. Current price/earnings ratio for Sumitomo Mitsui is 12.25.

  • Ibiden (4062.T) traded down -3.1 % and now trades at JPY 8,952. Current market capitalisation for Ibiden is JPY 4.7 trillions. Current price/earnings ratio for Ibiden is 71.32.

About Suzuki Motor

The Suzuki Motor Corporation is a global automobile manufacturer with production facilities in the United States, Japan, Taiwan, India, Pakistan, Indonesia, Thailand, and Hungary. The company specializes in manufacturing automobiles, motorcycles, and their related parts.